$CRUS
CIRRUS LOGIC, INC.

2023 Q3 Form 10-Q Financial Statement

#000077240623000048 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $481.1M $317.0M
YoY Change -11.01% -19.47%
Cost Of Revenue $234.5M $157.6M
YoY Change -12.93% -17.47%
Gross Profit $246.6M $159.4M
YoY Change -9.1% -21.34%
Gross Profit Margin 51.26% 50.28%
Selling, General & Admin $34.32M $35.38M
YoY Change -13.32% -8.44%
% of Gross Profit 13.92% 22.2%
Research & Development $104.2M $106.2M
YoY Change -9.76% -3.19%
% of Gross Profit 42.26% 66.64%
Depreciation & Amortization $11.70M $11.94M
YoY Change -32.05% -27.7%
% of Gross Profit 4.74% 7.49%
Operating Expenses $140.8M $141.6M
YoY Change -9.17% -4.56%
Operating Profit $105.7M $17.79M
YoY Change -9.01% -67.22%
Interest Expense $3.700M $4.600M
YoY Change 187.94% 1408.2%
% of Operating Profit 3.5% 25.85%
Other Income/Expense, Net -$70.00K $377.0K
YoY Change -123.73% -25.49%
Pretax Income $109.4M $22.77M
YoY Change -7.12% -58.67%
Income Tax $34.00M $7.170M
% Of Pretax Income 31.08% 31.49%
Net Earnings $75.41M $15.60M
YoY Change -13.51% -60.71%
Net Earnings / Revenue 15.68% 4.92%
Basic Earnings Per Share $1.38 $0.28
Diluted Earnings Per Share $1.34 $0.28
COMMON SHARES
Basic Shares Outstanding 54.71M shares 54.81M shares
Diluted Shares Outstanding 56.28M shares 56.63M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $312.4M $388.1M
YoY Change -17.55% -2.42%
Cash & Equivalents $277.8M $352.3M
Short-Term Investments $34.60M $35.77M
Other Short-Term Assets $71.29M $173.6M
YoY Change 7.73% 277.77%
Inventory $328.9M $301.0M
Prepaid Expenses $32.84M $33.44M
Receivables $271.9M $186.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.097B $1.049B
YoY Change 14.67% 21.8%
LONG-TERM ASSETS
Property, Plant & Equipment $171.0M $292.8M
YoY Change 7.77% 86.29%
Goodwill $435.9M $435.9M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $40.00M $38.03M
YoY Change -18.39% -32.05%
Other Assets $44.05M $204.7M
YoY Change -38.11% 213.84%
Total Long-Term Assets $1.008B $1.008B
YoY Change -16.56% -19.04%
TOTAL ASSETS
Total Short-Term Assets $1.097B $1.049B
Total Long-Term Assets $1.008B $1.008B
Total Assets $2.104B $2.057B
YoY Change -2.75% -2.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $87.34M $75.94M
YoY Change -25.98% -37.47%
Accrued Expenses $97.90M $87.15M
YoY Change 2.56% 6.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $201.2M $202.9M
YoY Change -28.75% -19.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.277M $196.9M
YoY Change -96.8% -22.5%
Total Long-Term Liabilities $194.9M $196.9M
YoY Change -14.17% -22.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $201.2M $202.9M
Total Long-Term Liabilities $194.9M $196.9M
Total Liabilities $396.1M $399.8M
YoY Change -22.25% -21.1%
SHAREHOLDERS EQUITY
Retained Earnings -$1.213M -$33.62M
YoY Change -102.96% -670.43%
Common Stock $1.713B $1.693B
YoY Change 5.84% 6.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.708B $1.657B
YoY Change
Total Liabilities & Shareholders Equity $2.104B $2.057B
YoY Change -2.75% -2.34%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $75.41M $15.60M
YoY Change -13.51% -60.71%
Depreciation, Depletion And Amortization $11.70M $11.94M
YoY Change -32.05% -27.7%
Cash From Operating Activities -$22.70M -$39.81M
YoY Change -163.07% -153.54%
INVESTING ACTIVITIES
Capital Expenditures $8.500M $12.31M
YoY Change -182.95% 81.67%
Acquisitions
YoY Change
Other Investing Activities -$600.0K -$2.324M
YoY Change -154.01% 372.36%
Cash From Investing Activities -$9.200M -$14.63M
YoY Change 0.7% 89.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -42.60M -38.99M
YoY Change -16.71% -31.75%
NET CHANGE
Cash From Operating Activities -22.70M -39.81M
Cash From Investing Activities -9.200M -14.63M
Cash From Financing Activities -42.60M -38.99M
Net Change In Cash -74.50M -93.44M
YoY Change 206.69% -1081.39%
FREE CASH FLOW
Cash From Operating Activities -$22.70M -$39.81M
Capital Expenditures $8.500M $12.31M
Free Cash Flow -$31.20M -$52.12M
YoY Change -167.48% -177.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
218000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
218000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8101000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-549000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10278000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-20327000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
20079000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
24030000 usd
CY2023Q2 crus Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
3166000 usd
CY2022Q2 crus Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
3164000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39813000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74365000 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
11048000 usd
CY2022Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4694000 usd
CY2023Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13372000 usd
CY2022Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5186000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12310000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6776000 usd
CY2023Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2022Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
448000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14634000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7716000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
560000 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
120000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1047000 usd
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
866000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38504000 usd
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
56382000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38991000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57128000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93438000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9521000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
445784000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
369814000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1599817000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39707000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-379000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-967000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-746000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
56383000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18138000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1599187000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1658282000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-16000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-450000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-482000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
38855000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22715000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1656794000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
75703000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1918000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
73794000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1900000 usd
CY2023Q2 crus Available For Sale Securities Amortized Cost On Gross Unrealized Losses
AvailableForSaleSecuritiesAmortizedCostOnGrossUnrealizedLosses
73100000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
47000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1600000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
73376000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
108000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1997000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
71487000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000000 usd
CY2023Q1 crus Available For Sale Securities Amortized Cost On Gross Unrealized Losses
AvailableForSaleSecuritiesAmortizedCostOnGrossUnrealizedLosses
64000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
56300000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1900000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
36749000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
35765000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
35824000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
34978000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
38954000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
38029000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
37552000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
36509000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
75703000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
73794000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
73376000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
71487000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q2 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
73794000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
71487000 usd
CY2023Q2 us-gaap Number Of Foreign Currency Derivatives Held
NumberOfForeignCurrencyDerivativesHeld
1 derivtive
CY2023Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
2700000 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
186033000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
150473000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
186033000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
150473000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
105315000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
116088000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
195641000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
117362000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
300956000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
233450000 usd
CY2023Q2 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
168300000 usd
CY2023Q2 crus Income Tax Examination Estimate Of Possible Loss Penalties Expense
IncomeTaxExaminationEstimateOfPossibleLossPenaltiesExpense
63700000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317016000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
393639000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317016000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
393639000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22770000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55087000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7170000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15380000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.315
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.279
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7200000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15400000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.315
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.279
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
32900000 usd
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
7400000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39707000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54862000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56277000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1769000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1527000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56631000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57804000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
347000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
386000 shares
CY2023Q2 crus Payments For Long Term Purchase Commitment Capacity Reservation Fee
PaymentsForLongTermPurchaseCommitmentCapacityReservationFee
60000000 usd
CY2023Q2 crus Prepayment Of Long Term Purchase Commitment On Future Purchases
PrepaymentOfLongTermPurchaseCommitmentOnFuturePurchases
195000000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 crus Number Of Product Lines
NumberOfProductLines
2 product_line

Files In Submission

Name View Source Status
0000772406-23-000048-index-headers.html Edgar Link pending
0000772406-23-000048-index.html Edgar Link pending
0000772406-23-000048.txt Edgar Link pending
0000772406-23-000048-xbrl.zip Edgar Link pending
crus-20230624.htm Edgar Link pending
crus-20230624.xsd Edgar Link pending
crus-20230624_def.xml Edgar Link unprocessable
crus-20230624_cal.xml Edgar Link unprocessable
crus-20230624_lab.xml Edgar Link unprocessable
crus-20230624_htm.xml Edgar Link completed
ex311-crus080323.htm Edgar Link pending
ex312-crus080323.htm Edgar Link pending
ex321-crus080323.htm Edgar Link pending
ex322-crus080323.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crus-20230624_pre.xml Edgar Link unprocessable